As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...